Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas
Mohit Kumar Jolly(Indian Institute of Science Bangalore), Herbert Levine(Boston University), Jason A. Somarelli(Duke Medical Center), Maya U. Sheth(Duke Medical Center), Adrian Biddle(Queen Mary University of London), Sharmila A. Bapat(National Centre for Cell Science), Samir Hanash(The University of Texas MD Anderson Cancer Center), Annapoorni Rangarajan(Laboratory of Molecular Genetics), Andrew J. Armstrong(Duke University), S. C. Tripathi(All India Institute of Medical Sciences Bhopal)
Cited by 337
Related Papers
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
Detection and localization of surgically resectable cancers with a multi-analyte blood test
|Science|2018|2.8k
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
|Journal of Clinical Oncology|2016|1.6k
Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation
|The EMBO Journal|2001|855